z-logo
open-access-imgOpen Access
CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
Author(s) -
Ширинский Валерий Степанович,
Е В Казыгашева,
Н. Ю. Калиновская,
И. В. Ширинский
Publication year - 2017
Publication title -
medicinskaâ immunologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.133
H-Index - 6
eISSN - 2313-741X
pISSN - 1563-0625
DOI - 10.15789/1563-0625-2017-2-165-174
Subject(s) - fenofibrate , medicine , osteoarthritis , womac , body mass index , clinical endpoint , diabetes mellitus , randomized controlled trial , gastroenterology , endocrinology , alternative medicine , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here